Gelita Announces Promising New Information to Help People Cope With Osteoarthritis And Chronic Joint Pain
Leading Expert from Penn State University teams with World Class Triathlete Timo Bracht to present information at the Health and Fitness Summit conducted by the American College of Sports Medicine
Las Vegas, NV (PRWEB) March 31, 2005
Dr. Kristine Clark, Assistant Professor of Nutrition at Penn State University will be a featured presenter at the 2005 Health Summit and will be highlighting the essential importance of collagen hydrolysate in the treatment of osteoarthritis and improving joint health. As one of the country’s leading nutritionists, Dr. Clark has worked with the US Women’s Soccer team and is a current member of the sports medicine advisory board of the US Olympic Committee. Her work has demonstrated the importance of nutrition and the use of collagen hydrolysate in maintaining good joint health. Joining Dr. Clark at the Summit is world class triathlete Timo Bracht, fresh off an impressive showing at the California Half Ironman in San Diego a few weeks ago. Timo will be on hand during the Summit to discuss his comprehensive training program that includes the daily use of collagen hydrolysate, CH-Alpha™, and its impact on physical activity.
An Epidemic Condition that Dramatically Limits Physical Activity
Chronic joint pain is one of the most common disorders in the United States, affecting approximately 70 million Americans. Osteoarthritis affects approximately 20.7 million Americans, making it the most common musculoskeletal condition.1 To date, there is no cure; analgesics and antirheumatics only relieve pain or suppress the inflammation process. Current research suggests that development of the disease may be linked to defective cartilage metabolism. Supplementation with collagen hydrolysate, a collection of naturally collagenous peptides, has been shown to improve symptoms of osteoarthritis.
The Impact of Collagen Hydrolysate on Cartilage and Joint Health
Collagen hydrolysate (CH), a natural product derived from collagen, has been shown to stimulate cartilage regeneration. Collagen hydrolysate is a collection of bioactive collagen peptides, which allows for easy absorption into the blood stream. To date, clinical studies have shown that collagen hydrolysate may be able to protect joints from damage, strengthen joints and reduce pain from conditions like osteoarthritis.2 Many individuals could benefit from using collagen hydrolysate to improve joint function and maintain an active lifestyle. Older individuals, competitive athletes, recreational exercisers, those engaging in repetitive motion activities and individuals who are overweight and sedentary can improve joint health by taking CH-Alpha, a
Collagen hydrolysate dietary supplement. CH-Alpha contains 10 g of collagen hydrolysate and is taken daily.
A New and Different Way to Intervene
Currently, only symptomatic treatment for osteoarthritis is available. Development of the disease may be linked to defective cartilage metabolism. Collagen hydrolysate provides the specific amino acids—glycine, proline and 4-hydroxyproline—needed for joint cartilage synthesis. Collagen hydrolysate accumulates in joint cartilage and stimulates collagen production.1
Related Information
The GELITA GROUP established the GELITA Health Initiative to promote research in the use of collagen hydrolysate and its impact in the area of degenerative joint disease. GELITA Health Products recently developed a collagen hydrolysate dietary supplement, CH-Alpha. GELITA has been supporting scientific research of collagen hydrolysate since the late 1970Â’s.
For more information, contact:
Amy Maggio
Torre Lazur-McCann Communications
312-617-6248
Amy. maggio@mccann. com
Or -
Allison Ward Moore
The Ward Group
920-499-1328
Moore. pr@gmail. com
Or -
Lara Niemann
GELITA Health Initiative
712-943-1692
Lara. niemann@gelita. com
This press release was issued through GroupWeb EmailWire. Com. For more information on press release distribution, go to http://www. emailwire. com (http://www. emailwire. com).
# # #
